Head-to-head comparisons of medication uses, side effects, warnings, and more.
Farydak (panobinostat)
Cyclophosphamide
Farydak (panobinostat)
Cyclophosphamide
Summary of Farydak vs. Cyclophosphamide
Summary for Histone deacetylase inhibitor
Farydak (panobinostat) is a medication that's taken by mouth for the treatment of multiple myeloma (a type of bone marrow cancer). It was initially approved to be a part of a treatment that also included Velcade (bortezomib) and dexamethasone (Taperdex). It was only to be used by certain people for whom previous chemotherapy treatments didn't work well. Farydak (panobinostat) has been discontinued by the manufacturer and is no longer available in the United States.
Summary for Anticancer agent
Prescription only
Cyclophosphamide is an anticancer medication used in the treatment of many types of adult and childhood cancers, as well as a certain type of kidney problem in children (nephrotic syndrome). It’s typically used in combination with other anticancer medications. Depending on the treatment regimen, cyclophosphamide can be taken as a pill by mouth or injected into the veins (intravenously or IV). This medication can cause serious bladder and kidney problems, so it’s important to stay well hydrated during treatment.